BioComp Pharma

Name

BioComp Pharma

Legal name

BioComp Pharma, Inc.

Website

https://biocomppharma.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ)

akta.pro secondary industries

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Generic prescription drugs
• Authorized generic distribution
• Pharmaceutical manufacturing
• Generic drug development
• Therapeutic alternatives

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure

Revenue model

1. Generic Prescription Drug Sales: Revenue generated from development, sourcing, and commercialization of generic prescription drugs. The company offers a portfolio of generic and therapeutic alternative products across various therapeutic categories, sold to healthcare providers and pharmacies.
2. Authorized Generic Distribution: BioComp is the authorized generic distributor for Mission Pharmacal's brand products. The company distributes generic versions of parent company brands, leveraging competitive speed and cost positioning to maximize market penetration.
3. Product Commercialization Services: Turnkey solutions to commercialization including labeling coordination, packaging, warehousing, distribution, EDI capabilities, account management/sales, and accounting services for partners.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

BioComp Pharma develops, sources, and commercializes generic prescription drugs and authorized generic versions of Mission Pharmacal brand products. The company manufactures these products in a US cGMP-certified facility and distributes them to pharmacies, healthcare providers, and pharmaceutical partners across the United States.

Product overview

BioComp Pharma is a US-based pharmaceutical company and wholly-owned subsidiary of Mission Pharmacal Company focused on the development, sourcing, and commercialization of generic prescription drugs. The company offers a diverse portfolio of generic and authorized generic products across multiple therapeutic categories including antihistamines (Carbinoxamine Maleate), anticonvulsants/neuropathic pain (Gabapentin Oral Solution), potassium supplements (Potassium Citrate), corticosteroids (Prednisolone Sodium Phosphate), topical dermatologicals (Sodium Sulfacetamide/Sulfur products and Urea creams), and specialty medications (Tinidazole, Tiopronin). Products are developed and manufactured in the USA under cGMP conditions. The company provides turnkey commercialization solutions including labeling coordination, packaging, warehousing, distribution, EDI capabilities, and account management. The R&D team has over 40 years of formulation experience.

Differentiator

Problem solved

Functional benefit

Products and services

• Carbinoxamine Maleate Tablets USP 4mg Rx-only antihistamine tablet for allergic conditions; compares to Clistin® with therapeutic rating AA; available in 100-tablet packs.
• Gabapentin Oral Solution 250mg/5mL Rx-only anticonvulsant/neuropathic pain oral solution; compares to Neurontin®; available in 470 mL bottles.
• Potassium Citrate 10mEq Extended-Release Tablets Rx-only authorized generic potassium supplement for renal tubular acidosis; compares to Urocit®-K 10mEq; therapeutic rating AB; available in 100-tablet packs.
• Potassium Citrate 15mEq Extended-Release Tablets Rx-only authorized generic potassium supplement for renal tubular acidosis; compares to Urocit®-K 15mEq; available in 100-tablet packs.
• Prednisolone Sodium Phosphate Oral Solution 25mg/5mL Rx-only corticosteroid oral solution for inflammatory and allergic conditions; compares to Orapred®; available in 8 fl. oz. bottles.
• Sodium Sulfacetamide 10% Wash Rx-only topical antibiotic wash for acne and skin conditions; available in 6, 12, and 16 fl. oz. sizes.
• Sodium Sulfacetamide 10% Cleansing Gel Rx-only topical antibiotic cleansing gel for acne and rosacea treatment; available in 12 fl. oz. tubes.
• Sodium Sulfacetamide 8% and Sulfur 4% Suspension Rx-only topical suspension for acne treatment combining sodium sulfacetamide with sulfur.
• Sodium Sulfacetamide 9% and Sulfur 4.5% Wash Rx-only topical wash formulation for acne-prone skin.
• Sodium Sulfacetamide 9.8% and Sulfur 4.8% Cleanser Rx-only topical cleanser for acne treatment.
• Sodium Sulfacetamide 10% and Sulfur 2% Cleanser Rx-only topical acne treatment cleanser.
• Sodium Sulfacetamide 10% and Sulfur 5% Emollient Cream Rx-only emollient cream combining sodium sulfacetamide and sulfur for skin conditions.
• Sodium Sulfacetamide 10% w/v and Sulfur 5% w/v Lotion Rx-only topical lotion formulation for acne treatment.
• Sodium Sulfacetamide 10% and Sulfur 5% Suspension Rx-only topical suspension for acne treatment.
• Tinidazole Tablets 500mg Rx-only authorized generic antiprotozoal and antibacterial tablet; compares to Tindamax®; available in 12- and 20-tablet packs.
• Tiopronin Delayed-Release Tablets 100mg Rx-only authorized generic chelating agent for cystinuria; compares to Thiola EC® 100mg with therapeutic rating AB; available in 300-tablet packs.
• Tiopronin Delayed-Release Tablets 300mg Rx-only authorized generic chelating agent for cystinuria; compares to Thiola EC® 300mg; available in 90-tablet packs.
• Urea 20% Cream Rx-only moisturizing cream for dry skin conditions; compares to Carmol® 20; available in 3 oz. tubes.
• Urea 39% Cream Rx-only high-concentration moisturizing cream for dry skin conditions; compares to Aluvea™ Cream; available in 8 oz. sizes.
• Urea 40% Cream Rx-only high-concentration moisturizing cream for severe dry skin; compares to Carmol® 40; available in 1 oz. sizes.
• Turnkey Product Commercialization Services End-to-end commercialization support offered to pharmaceutical partners, including labeling coordination, packaging, warehousing, distribution, EDI capabilities, account management/sales, and accounting services.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

One partnership is on record.

• Mission Pharmacal CompanycoreStrategic or Co-development PartnerBioComp Pharma is a wholly-owned subsidiary of Mission Pharmacal Company. BioComp serves as the authorized generic distributor for Mission Pharmacal's brand products. This relationship provides BioComp with established brand products for generic commercialization and leverages Mission Pharmacal's product portfolio for market expansion.

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Endo International: Large diversified specialty and generic pharmaceutical company with operations in sterile injectables, generics, and branded specialty. Overlaps with BioComp in the generic and authorized-generic distribution channel but operates at far greater scale and broader portfolio.
• Glenmark Pharmaceuticals: Global generic and specialty pharmaceutical company with US operations distributing generics across dermatology, CNS, and anti-infective categories. Comparable product mix to BioComp, but operates globally and at much larger scale.
• Teva Pharmaceutical Industries: World's largest generic pharmaceutical manufacturer, offering an extensive portfolio of oral solids, injectables, and specialty generics through US pharmacy and wholesaler channels. Operates in the same product categories and channels as BioComp but at vastly greater scale and breadth.
• Aurobindo Pharma USA: US arm of a large global generic manufacturer offering oral solids, injectables, and topical generics sold through pharmacy and wholesaler channels. Comparable generics distribution model but at substantially greater scale than BioComp.
• Sandoz (Novartis): Global leader in off-patent medicines including generics and biosimilars, distributing across the same US pharmacy channels as BioComp. A broad incumbent that competes in overlapping therapeutic categories but at materially greater scale.

Direct peers

• Lannett Company: US-based generic pharmaceutical manufacturer and distributor offering solid oral dose generics and specialty products. Comparable to BioComp as a US-domiciled generic manufacturer/distributor with focus on limited-competition molecules.
• Upsher-Smith Laboratories: Private US-based specialty and generic pharmaceutical company that develops, manufactures, and distributes prescription generics and authorized generics across multiple therapeutic categories. Highly comparable to BioComp in scale, niche-generic strategy, and B2B healthcare-provider distribution model.
• ANI Pharmaceuticals: US specialty/generic pharmaceutical manufacturer and distributor focused on niche, limited-competition molecules across therapeutic categories including generics, authorized generics, and specialty brands. Directly comparable to BioComp in product mix, niche focus, and commercial model.
• Amneal Pharmaceuticals: US-based generic and specialty pharmaceutical company developing, manufacturing, and distributing a broad portfolio of generics across multiple therapeutic categories including dermatology, CNS, and anti-infectives. Highly overlapping product categories and distribution channels with BioComp.

Others

• Mission Pharmacal Company: BioComp's parent company and strategic operating partner, supplying brand products that BioComp converts into authorized generics. Not a peer in the competitive sense, but the closest commercial relationship and a key channel for BioComp's pipeline.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biocomppharma

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioComp Pharma